Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...

Rortvedt (shoulder) went 0-for-2 with a strikeout in Saturday's 10-1 loss to the Mets in Grapefruit League play.

Private cataract removal work is so lucrative that consultants are cashing in and have less time for hospital appointments ...

As an advocate for the health of Australians, I am deeply concerned about the growing issue of access to treatment for those ...

Presented positive interim data through 52 weeks and beyond for 4D-150 in wet AMD from PRISM Phase 1/2 clinical trial highlighting robust and durable clinical activity across diverse patient populatio ...

University of Utah researchers have created a robotic surgery device that helps to minimise the effect of unintended movement ...

In the United States, ONS-5010 / LYTENAVA™ (bevacizumab-vikg) is investigational.

Reported $781.4 million in full year 2024 revenues, representing 97% year-over-year growth SYFOVRE® (pegcetacoplan injection) full year 2024 net product revenue of $611.9 millionEMPAVELI® (pegcetacopl ...

Presented 48-month data from the GALE extension study at The Macula Society Annual Meeting in February 2025 demonstrating that early treatment with SYFOVRE leads to preservation of retinal tissue at ...

Discover the secrets about facial filler and injections from top dermatologists, including what really happens beneath your ...

Rortvedt will not be allowed to throw for 3-to-4 days after being given an injection in his sore right shoulder Wednesday, MLB.com reports. The Rays are hopeful Rortvedt will be ready to return to ...

Retinal gene therapy advancements may rewrite the book on treatments for age-related macular degeneration and diabetic eye diseases.